Involvement of pigment epithelium-derived factor, docosahexaenoic acid and neuroprotectin D1 in corneal inflammation and nerve integrity after refractive surgery

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 1, 2013, Pages 27-31

  Kenchegowda, S ^a   He, J ^a   Bazan, H E P ^a  

^a LSU EYE CENTER   (United States)

Author keywords

Corneal damage; DHA; Nerve regeneration; NPD1; PEDF; Pigment epithelium

Indexed keywords

5,8,11,14,17 ICOSAPENTAENOIC ACID; ARACHIDONIC ACID; CALCITONIN GENE RELATED PEPTIDE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LEUKOTRIENE B4; LIPOXIN A; NEUROPROTECTIN D1; OMEGA 6 FATTY ACID; PIGMENT EPITHELIUM DERIVED FACTOR; PIGMENT EPITHELIUM DERIVED FACTOR RECEPTOR; RECEPTOR; RESOLVIN E1; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOCRINE EFFECT; CORNEA EPITHELIUM; CORNEA INJURY; DIET SUPPLEMENTATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRY EYE; EPITHELIUM CELL; FATTY ACID SYNTHESIS; HUMAN; INTRACELLULAR SIGNALING; KERATITIS; NERVE INJURY; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REFRACTIVE SURGERY;

ANIMALS; CORNEA; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EPITHELIUM, CORNEAL; EYE PROTEINS; HUMANS; KERATITIS; MODELS, BIOLOGICAL; NERVE GROWTH FACTORS; NERVE REGENERATION; OPHTHALMIC NERVE; REFRACTIVE SURGICAL PROCEDURES; SERPINS;

EID: 84872037898     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2012.03.010     Document Type: Article

References (59)

1. Müller L.J., Marfurt C.F., Kruse F., Tervo T.M. Corneal nerves: structure, Content and function. Exp. Eye Res. 2003, 76:521-542.
2. Marfurt C.F., Cox J., Deek S., Dvorscak L. Anatomy of the human corneal Innervation. Exp. Eye Res. 2010, 90:478-492.
3. He J., Bazan N.G., Bazan H.E. Mapping the entire human corneal nerve architecture. Exp. Eye Res. 2010, 91(4):513-523.
4. Belmonte C., Acosta M.C., Gallar J. Neural basis of sensation in intact and injured corneas. Exp. Eye Res. 2004, 78:513-525.
5. Patel D.V., McGhee C.N. In vivo confocal microscopy of human corneal nerves in health, in ocular and systemic disease, and following corneal surgery: a review. Br. J. Ophthalmol 2009, 93:853-860.
6. Rosenberg M.E., Tervo T.M., Immonen I.J., Müller L.J., Grönhagen-Riska C., Vesaluoma M.H. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest. Ophthalmol.Vis. Sci. 2000, 41:2915-2921.
7. Su D.H., Wong T.Y., Foster P.J., Tay W.T., Saw S.M., Aung T. Central corneal thickness and its associations with ocular and systemic factors: the Singapore Malay Eye Study. Arch. Ophthalmol. 2008, 26:981-985.
8. Jeganathan V.S., Wang J.J., Wong T.Y. Ocular associations of diabetes other than diabetic Retinopathy. Diabetes Care. 2008, 31:1905-1912.
9. He J., Bazan H.E. Mapping the nerve architecture of diabetic human corneas. Ophthalmology 2012, 119:956-964.
10. Erie J.C., McLaren J.W., Hodge D.O., Bourne W.M. Recovery of corneal subbasal nerve density after PRK and LASIK. Am. J. Ophthalmol. 2005, 140:1059-1064.
11. Jackson M.A., Burrell K., Gaddie I.B., Richardson S.D. Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A. Clin. Ophthalmol. 2011, 5:1201-1206.
12. Wojtowicz J.C., Butovich I., Uchiyama E., Aronowicz J., Agee S., McCulley J.P. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea 2011, 30:308-314.
13. Viau S., Maire M.A., Pasquis B., et al. Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 247:1039-1050.
14. Miljanović B., Trivedi K.A., Dana M.R., Gilbard J.P., Buring J.E., Schaumberg D.A. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am. J. Clin. Nutr. 2005, 82:887-893.
15. Brignole-Baudouin F., Baudouin C., Aragona P., et al. A multicentre, double- masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol. 2011, 89:591-597.
16. Serhan C.N., Hong S., Gronert K., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 2002, 196:1025-1037.
17. Li N., He J., Schwartz C.E., Gjorstrup P., Bazan H.E. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J. Ocul. Pharmacol. Ther. 2010, 26:431-439.
18. Cortina M.S., Bazan H.E. Docosahexaenoic acid, protectins and dry eye. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14:132-137.
19. Becerra S.P. Focus on Molecules: pigment epithelium-derived factor (PEDF). Exp. Eye 2006, 82:739-740.
20. Tombran-Tink J., Shivaram S.M., Chader G.J., Johnson L.V., Bok D. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J. Neurosci. 1995, 15:4992-5003.
21. Ablonczy Z., Prakasam A., Fant J., Fauq A., Crosson C., Sambamurti K. Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase. J. Biol. Chem. 2009, 284:30177-30186.
22. He S., Kumar S.R., Zhou P., et al. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro. Invest. Ophthalmol. Vis. Sci. 2010, 51:543-552.
23. Tombran-Tink J., Barnstable C.J. PEDF: a multifaceted neurotrophic factor. Nat. Rev. Neurosci. 2003, 4:628-636.
24. Cao W., Tombran-Tink J., Chen W., Mrazek D., Elias R., McGinnis J.F. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide- induced cell death. J. Neurosci. Res. 1999, 57:789-800.
25. DeCoster M.A., Schabelman E., Tombran-Tink J., Bazan N.G. Neuroprotection by pigment epithelial-derived factor against glutamate toxicity in developing primary hippocampal neurons. J. Neurosci. Res. 1999, 56:604-610.
26. Houenou L.J., D'Costa A.P., Li L., et al. Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J. Comp. Neurol. 1999, 412:506-514.
27. Bilak M.M., Becerra S.P., Vincent A.M., Moss B.H., Aymerich M.S., Kuncl R.W. Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J Neurosci. 2002, 22:9378-9386.
28. Mukherjee P.K., Marcheselli V.L., Barreiro S., Hu J., Bok D., Bazan N.G. Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proc. Natl. Acad. Sci. USA 2007, 104:13152-13157.
29. Bannenberg G., Serhan C.N. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim. Biophys. Acta 2010, 1801:1260-1273.
30. Stark D.T., Bazan N.G. Neuroprotectin D1 induces neuronal survival and down regulation of amyloidogenic processing in Alzheimer's disease cellular models. Mol. Neurobiol. 2011, 43:131-138.
31. Bazan N.G., Musto A.E., Knott E.J. Endogenous signaling by omega-3 Docosa hexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol. Neurobiol. 2011, 44:216-222.
32. Bazan N.G., Calandria J.M., Serhan C.N. Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1. J. Lipid Res. 2010, 51:2018-2031.
33. Calandria J.M., Bazan N.G. Neuroprotectin D1 modulates the induction of pro- inflammatory signaling and promotes retinal pigment epithelial cell survival during oxidative stress. Adv. Exp. Med. Biol. 2010, 664:663-670.
34. Cortina M.S., He J., Li N., Bazan N.G., Bazan H.E. Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA. Invest. Ophthalmol. Vis. Sci. 2010, 51:804-810.
35. Cortina M.S., He J., Li N., Bazan N.G., Bazan H.E. Recovery of corneal sensitivity, calcitonin gene- related Peptide-positive nerves, and increased wound healing induced by pigment epithelial-derived factor plus docosahexaenoic Acid after experimental surgery. Arch. Ophthalmol. 2012, 130:76-83.
36. Wilson S.E., Chen L., Mohan R.R., Liang Q., Liu J. Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp. Eye Res. 1999, 68:377-397.
37. Kakazu A., Chandrasekher G., Bazan H.E. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway. Invest. Ophthalmol. Vis. Sci. 2004, 45:3485-3492.
38. Ottino P., Taheri F., Bazan H.E. Growth factor-induced proliferation in corneal epithelial cells is mediated by 12(S)-HETE. Exp. Eye Res. 2003, 76:613-622.
39. Chandrasekher G., Kakazu A.H., Bazan H.E. HGF and KGF-induced activation of PI-3K/p70 s6 kinase pathway in corneal epithelial cells: its relevance in wound Healing. Exp. Eye Res. 2001, 73:191-202.
40. Lambiase A., Manni L., Bonini S., et al. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest. Ophthalmol. Vis. Sci. 2000, 41:1063-1069.
41. Tuli S.S., Liu R., Chen C., Blalock T.D., Goldstein M., Schultz G.S. Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation. Curr. Eye Res. 2006, 31:709-719.
42. Kenchegowda S., Bazan N.G., Bazan H.E. EGF stimulates lipoxin A4 synthesis and modulates repair in corneal epithelial cells through ERK and p38 activation. Invest Ophthalmol. Vis. Sci. 2011, 52:2240-2249.
43. Chandrasekher G., Bazan H.E. Corneal epithelial wound healing increases the expression but not long lasting activation of the p85alpha subunit of phosphatidylinositol-3 kinase. Curr. Eye Res. 1999, 18:168-176.
44. Notari L., Baladron V., Aroca-Aguilar J.D., et al. Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor. J. Biol. Chem. 2006, 281:38022-38037.
45. Hirsch J., Johnson C.L., Nelius T., Kennedy R., Riese W., Filleur S. PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ. Cytokine 2011, 55:202-210.
46. Bazan H.E., Bazan N.G. Composition of phospholipids and free fatty acids and incorporation of labeled arachidonic acid in rabbit cornea. Comparison of epithelium, stroma and endothelium. Curr. Eye Res. 1984, 3:1313-1319.
47. Bazan H.E., Reddy S.T., Lin N. Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. Exp. Eye Res. 1991, 52:481-491.
48. Hurst J.S., Balazy M., Bazan H.E., Bazan N.G. The epithelium, endothelium, and stroma of the rabbit cornea generate (12S)-hydroxyeicosatetraenoic acid as the main lipoxygenase metabolite in response to injury. J. Biol. Chem. 1991, 266:6726-6730.
49. Lin N., Hurst J., Bazan H.E. Increased synthesis of specific eicosanoids in rejected corneal grafts. Curr. Eye Res. 1996, 15:1208-1212.
50. Bazan H.E., Birkle D.L., Beuerman R., Bazan N.G. Cryogenic lesion alters the metabolism of arachidonic acid in rabbit cornea layers. Invest Ophthalmol. Vis. Sci. 1985, 26:474-480.
51. Bazan H.E. Corneal injury alters eicosanoid formation in the rabbit anterior segment in vivo. Invest. Ophthalmol. Vis. Sci. 1987, 28:314-319.
52. Bazan H.E., Tao Y., DeCoster M.A., Bazan N.G. Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway. Invest. Ophthalmol. Vis. Sci. 1997, 38:2492-2501.
53. Pfister R.R., Haddox J.L., Sommers C.I. Injection of chemoattractants into normal cornea: a model of inflammation after alkali injury. Invest. Ophthalmol. Vis. Sci. 1998, 39:1744-1750.
54. Kernacki K.A., Berk R.S. Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa. Invest. Ophthalmol. Vis. Sci. 1995, 36:16-23.
55. Calandria J.M., Bazan N.G. Neuroprotectin D1 modulates the induction of pro- inflammatory signaling and promotes retinal pigment epithelial cell survival during oxidative stress. Adv. Exp. Med. Biol. 2010, 664:663-670.
56. Faghiri Z., Bazan N.G. PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis. Exp. Eye Res. 2010, 90:718-725.
57. Marcheselli V.L., Mukherjee P.K., Arita M., et al. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82:27-34.
58. Cortina M.S., He J., Russ T., Bazan N.G., Bazan H.E. Topical treatment with Neuroprotectin D1 increases corneal nerve regeneration after experimental surgery. ARVO Poster 2011, 982.
59. Calandria J.M., Marcheselli V.L., Mukherjee P.K., et al. Selective survival rescue in 15- lipoxygenase-1-deficient pigment epithelial cells by the novel docosahexaenoic acid derived mediator, neuroprotectin D1. J. Biol. Chem. 2009, 284:17877-17882.